Our Cannabis Research

CIITECH CLINICAL RESEARCH HEBREW UNIVERSITY CBD CANNABIS UK ISRAEL MECHOULAM TAM OBESITY ASTHMA

CiiTECH was founded to fulfill the need for well researched and developed therapeutic cannabis products (initially derived) from Hemp (Cannabis Sativa L).   Our edge in a competitive and confusing CBD landscape is our unflinching passion to contribute to the revealing of the many scientific mysteries of the plant still yet to be uncovered.

To this end we are proud to have partnered with the world-famous Hebrew University of Jerusalem on some of the most exciting cannabinoid R&D taking place today.

In 2017 CiiTECH sponsored two clinical research projects to investigate and prove the potential for CBD to treat; Asthma & NAFLD (Obesity Induced Fatty Liver Disease).

CANNABIS R&D PROJECT 1 

A study to identify a possible inhibitory effect of a CBD derivative to inhibit allergic airway inflammation asthma

CANNABIS R&D PROJECT 2 

A study into the Therapeutic Effect of CBD for obesity induced Nonalcoholic Fatty Liver Disease NAFLD

CIITECH

2021 ©